Aberdeen Group plc Reduces Stock Position in Stryker Corporation $SYK

Aberdeen Group plc reduced its holdings in shares of Stryker Corporation (NYSE:SYK) by 4.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 295,845 shares of the medical technology company’s stock after selling 12,821 shares during the period. Aberdeen Group plc’s holdings in Stryker were worth $103,981,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Clayton Financial Group LLC bought a new stake in Stryker during the third quarter worth approximately $26,000. United Financial Planning Group LLC bought a new stake in Stryker in the third quarter worth about $27,000. Elevation Point Wealth Partners LLC purchased a new position in shares of Stryker during the second quarter valued at approximately $28,000. Kilter Group LLC bought a new position in shares of Stryker during the second quarter valued at approximately $29,000. Finally, Howard Hughes Medical Institute purchased a new stake in shares of Stryker in the second quarter worth approximately $29,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Stryker in a research note on Monday, December 22nd. BTIG Research increased their target price on Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Robert W. Baird set a $437.00 target price on Stryker in a research report on Friday, January 30th. William Blair reissued an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Finally, Sanford C. Bernstein upped their price target on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a report on Friday, January 9th. Fourteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.50.

Insider Buying and Selling

In related news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 5.90% of the stock is currently owned by corporate insiders.

Stryker Price Performance

Shares of SYK opened at $331.48 on Friday. Stryker Corporation has a twelve month low of $319.32 and a twelve month high of $404.87. The company has a 50 day moving average of $357.10 and a two-hundred day moving average of $361.96. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The company has a market cap of $126.95 billion, a price-to-earnings ratio of 39.46, a price-to-earnings-growth ratio of 1.94 and a beta of 0.92.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion during the quarter, compared to analysts’ expectations of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The firm’s revenue was up 11.4% compared to the same quarter last year. During the same period last year, the business posted $4.01 earnings per share. As a group, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s payout ratio is currently 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.